Compare BridgeBio Pharma Inc (BBIO) vs Baidu Inc (BIDU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Baidu Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while Baidu Inc trades at $104.76 (market cap $37.11B). The key difference: Baidu Inc is far larger — about 2.2× BridgeBio Pharma Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Baidu Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | BIDU | |
|---|---|---|
Market Cap | $16.61B | $37.11B |
Sector | Health | Media |
52-Week High | $90.17 | $162.52 |
52-Week Low | $47.29 | $86.76 |
Enterprise Value | $18.16B | $33.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →
